Intellia Therapeutics (NASDAQ:NTLA) Upgraded at StockNews.com
StockNews.com upgraded shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) to a sell rating in a research report sent to investors on Monday. A number of other brokerages have also commented on NTLA. Morgan Stanley lowered Intellia Therapeutics from an “overweight” rating to an “equal weight” rating and decreased their target price for the company […]
StockNews.com upgraded shares of Intellia Therapeutics (NASDAQ:NTLA – Free Report) to a sell rating in a research report sent to investors on Monday. A number of other brokerages have also commented on NTLA. Morgan Stanley lowered Intellia Therapeutics from an “overweight” rating to an “equal weight” rating and decreased their target price for the company […]
